Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKansas City Heart Rhythm Research Foundation
About this trial
This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.
Eligibility criteria
Qualifiers
All patients older than 18 years of age
Patients with HFrEF that underwent BVP-CRT
Experienced CS lead failure, whether initial or recurrent, subsequently replaced with transthoracic epicardial lead placement or CSP
Underwent Medtronic, Boston Scientific, or Abbott lead placement
Disqualifiers
Patients younger than 18 years of age
Transthoracic epicardial lead placement or CSP performed as the initial approach or for other reasons than lead replacement
Those for which CRT no longer provides symptom relief or mortality benefit.
Trial design
Treatments tested in this trial
- Coronary Sinus Lead Revision
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov